Provided By GlobeNewswire
Last update: Sep 29, 2025
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced that it has filed a final short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities regulatory authorities in each of the provinces of Canada, except Québec (the “Securities Regulators”) on September 26, 2025 (the “Effective Date”).
Read more at globenewswire.com